Evidence map›Paper›PMID 35431833›Full record

ArticleFrontiers in behavioral neuroscience2022

Trace Amine-Associated Receptor 2 Is Expressed in the Limbic Brain Areas and Is Involved in Dopamine Regulation and Adult Neurogenesis.

Evgeniya V Efimova, Saveliy R Kuvarzin, Mikael S Mor, Nataliia V Katolikova, Taisiia S Shemiakova, Valeria Razenkova, Maria Ptukha, Alena A Kozlova, Ramilya Z Murtazina, Daria Smirnova and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in behavioral neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Transcriptomic Analysis ofBrain sciences · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Effect of Combined Levothyroxine (L-TInternational journal of molecular sciences · 2023
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Evgeniya V EfimovaInstitute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.
Saveliy R KuvarzinInstitute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.
Mikael S MorInstitute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.
Nataliia V KatolikovaInstitute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.
Taisiia S ShemiakovaInstitute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.
Valeria RazenkovaInstitute of Experimental Medicine, St. Petersburg, Russia.
Maria PtukhaInstitute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.
Alena A KozlovaInstitute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.
Ramilya Z MurtazinaInstitute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.
Daria SmirnovaInstitute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.
Aleksandr A VeshchitskiiPavlov Institute of Physiology Russian Academy of Sciences, St. Petersburg, Russia.
Natalia S MerkulyevaPavlov Institute of Physiology Russian Academy of Sciences, St. Petersburg, Russia.
Anna B VolnovaInstitute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.
Pavel E MusienkoInstitute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.
Dmitrii E KorzhevskiiInstitute of Experimental Medicine, St. Petersburg, Russia.
Evgeny A BudyginDepartment of Neurobiology, Sirius University of Science and Technology, Sochi, Russia.
Raul R GainetdinovInstitute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.
St Petersburg University · RUPavlov Institute of Physiology of the Russian Academy of Sciences · RUInstitute of Experimental Medicine · RUSirius University of Science and Technology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trace amines are a group of biogenic amines that are structurally and functionally close to classical monoamine neurotransmitters. Trace amine-associated receptors (TAARs) are emerging as promising targets for treating neuropsychiatric disorders. It has been documented that all TAARs, apart from TAAR1, function as olfactory receptors involved in sensing innate odors encoded by volatile amines. However, recently, brain expression and function of TAAR5 were also demonstrated. In this study, we assessed the behavior, brain neurochemistry, and electrophysiology changes in knock-out mice lacking Trace amine-associated receptor 2 (TAAR2) but expressing beta-Galactosidase mapping expression of TAAR2 receptors. As expected, we detected beta-Galactosidase staining in the glomerular layer of the olfactory bulb. However, we also found staining in the deeper layers of the olfactory bulb and several brain regions, including the hippocampus, cerebellum, cortex, raphe nuclei, hypothalamus, and habenula, indicating that TAAR2 receptors are not only expressed in the olfactory system but are also present in the limbic brain areas that receive olfactory input. In behavioral experiments, TAAR2 knock-out (TAAR2-KO) mice showed increased locomotor activity and less immobility in the forced swim test, with no changes in anxiety level. Furthermore, TAAR2-KO mice showed alterations in brain electrophysiological activity-particularly, decreased spectral power of the cortex and striatum in the 0, 9-20 Hz range. TAAR2-KO mice also had elevated tissue dopamine levels in the striatum and an increased dopaminergic neuron number in the Substantia Nigra. In addition, an increased brain-derived neurotrophic factor (BDNF) mRNA level in the striatum and Monoamine Oxidase B (MAO-B) mRNA level in the striatum and midbrain was found in TAAR2-KO mice. Importantly, TAAR2-KO mice demonstrated an increased neuroblast-like and proliferating cell number in the subventricular and subgranular zone, indicating increased adult neurogenesis. These data indicate that in addition to its role in the innate olfaction of volatile amines, TAAR2 is expressed in limbic brain areas and regulates the brain dopamine system, neuronal electrophysiological activity, and adult neurogenesis. These findings further corroborated observations in TAAR1-KO and TAAR5-KO mice, indicating common for TAAR family pattern of expression in limbic brain areas and role in regulating monoamine levels and adult neurogenesis, but with variable involvement of each subtype of TAAR receptors in these functions.

Indexed as

BDNFdopaminelimbic systemneurogenesisTAAR2trace amine-associated receptors (TAARs)trace amines

Identifiers

PMID35431833
PMCPMC9011332
OpenAlexW4220744415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.